Qiagen N.V.

NYSE:QGEN

Sector

🏥 Health Care

Industries

🧬 Biotechnology

Location

Netherlands

Market Cap

USD 10.28 B

Share Price

USD 47.49

Avg Daily Volume

1,492,480

Change (1 day)

-4.92%

Change (1 year)

6.19%

Change (YTD)

6.65%

Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 680.21 M

Qiagen N.V. Operating Cash Flow is USD 680.21 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 30.66% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 520.61 M, a -10.21% change year over year.
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 579.78 M, a -19.23% change year over year.
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 717.78 M, a 25.81% change year over year.
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 570.52 M, a 88.90% change year over year.